ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Zhang et al. demonstrated in vivo that BM-MSC-derived Il-7 was a mechanism of BCR::ABL1-independent JAK1/STAT5-mediated TKI resistance in CML cell lines [96].